Fucosterol from Sargassum horridum as an amyloid-beta (Aβ1-42) aggregation inhibitor: in vitro and in silico studies

The number of patients diagnosed with Alzheimer's disease (AD) increases each year, and there are currently few treatment strategies to decrease the symptoms of AD; furthermore, these strategies are not sufficient to reduce memory loss in AD patients. In this work, in vitro and in silico studie...

Full description

Saved in:
Bibliographic Details
Published in:Journal of biomolecular structure & dynamics Vol. 39; no. 4; pp. 1271 - 1283
Main Authors: Castro-Silva, Elena Sthephanie, Bello, Martiniano, Rosales-Hernández, Martha Cecilia, Correa-Basurto, José, Hernández-Rodríguez, Maricarmen, Villalobos-Acosta, Daniel, Méndez-Méndez, Juan Vicente, Estrada-Pérez, Alan, Murillo-Álvarez, Jesus, Muñoz-Ochoa, Mauricio
Format: Journal Article
Language:English
Published: England Taylor & Francis 04-03-2021
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The number of patients diagnosed with Alzheimer's disease (AD) increases each year, and there are currently few treatment strategies to decrease the symptoms of AD; furthermore, these strategies are not sufficient to reduce memory loss in AD patients. In this work, in vitro and in silico studies were performed to evaluate the effects of fucosterol, which was extracted from an algal source and characterized by liquid chromatography-mass spectra (LC-MS), as an inhibitor of Aβ 1-42 aggregation. Experimental studies, including protein gel electrophoresis, atomic force microscopy and fluorescence studies with thioflavin T (ThT), highlighted that fucosterol can decrease oligomer formation more than galantamine, which was used as a positive control. Docking and molecular dynamics simulations coupled with an MMGBSA approach showed that fucosterol is capable of recognizing the hydrophobic regions of monomeric Aβ 1-42 , suggesting that fucosterol could affect amyloid-beta (Aβ 1-42 ) aggregation by preventing the formation of oligomers, preventing the development of AD. Communicated by Ramaswamy H. Sarma
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0739-1102
1538-0254
DOI:10.1080/07391102.2020.1729863